Mutagenesis
Mutagenesis: is a process by which the genetic information of an organism is changed, resulting in a mutation. It may occur spontaneously in nature, or as a result of exposure to mutagens. It can also be achieved experimentally using laboratory procedures.
-
OCT 08, 2020 7:30 AM PDTC.E. CREDITS
OCT 08, 2020 7:30 AM PDTIndividuals of under-represented minority ancestry are at disproportional risk for higher incidence and mortality rates for particular cancers. The unequal burden of cancer in certain racial...Speaker: Steven R. Patierno, PhDPresented at: Cancer Research & Oncology 2020JUN 17, 2020 12:00 PM PDTC.E. CREDITS
JUN 17, 2020 12:00 PM PDTJoin us and hear from two Luminex® experts on our flexible solutions for molecular diagnostics. Dr. Sherry Dunbar and Dr. Aaron Benfield will describe our NxTAG® bead-based nucleic a...Speaker: Aaron P. Benfield, PhD , Sherry A. Dunbar, PhD, MBAPresented at: Coronavirus Virtual Event SeriesSponsored By: LUMINEXOCT 10, 2019 1:30 PM PDTC.E. CREDITS
OCT 10, 2019 1:30 PM PDTMetastatic castration resistant prostate cancer (mCRPC) refractory to secondary hormonal treatments such as enzalutamide or abiraterone acetate are the most lethal of prostate cancers. In thi...Speaker: Tian Zhang, MD, MHSPresented at: Cancer Research & Oncology 2019OCT 10, 2019 12:00 PM PDTC.E. CREDITS
OCT 10, 2019 12:00 PM PDTTumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...Speaker: Ravindra Kolhe, MD, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: QIAGENOCT 10, 2019 10:30 AM PDTC.E. CREDITS
OCT 10, 2019 10:30 AM PDTOsteosarcoma (OS) is the most common bone tumor in pediatric and adolescent/young adult patients. Over the past three decades, significant improvements in the survival rates or therapeutic ap...Speaker: Troy McEachron, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: NanoString TechnologiesOCT 10, 2019 10:30 AM PDTC.E. CREDITS
OCT 10, 2019 10:30 AM PDTAccumulation of structural variations (SVs) across the genome is a known trigger factor for oncogenesis. Structural mutations have been clearly implicated in a number of cancers, most notably...Speaker: Sven Bocklandt, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: Bionano GenomicsOCT 10, 2019 9:00 AM PDTC.E. CREDITS
OCT 10, 2019 9:00 AM PDTCopy-number alterations and chromosomal translocations are widespread in cancer and frequently causing oncogenic mutations that drive tumorigenesis and therapy resistance. Despite their preva...Speaker: Cheng-Zhong Zhang, PhDPresented at: Cancer Research & Oncology 2019OCT 10, 2019 9:00 AM PDTC.E. CREDITS
OCT 10, 2019 9:00 AM PDTBlockade of CTLA-4 and PD-1, members of the B7/CD28 family, have proven to be the most successful cancer immunotherapies to date. While the current therapeutic focus remains on B7/CD28 family...Speaker: Anthony Persen, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: Bio-TechneOCT 09, 2019 12:00 PM PDTC.E. CREDITS
OCT 09, 2019 12:00 PM PDTThe introduction of robot-assisted surgical technology into urological practice, has introduced new horizons for reducing the morbidity and enhancing the efficacy of surgery. Open radical cys...Speaker: Khurshid Guru, MDPresented at: Cancer Research & Oncology 2019OCT 09, 2019 10:30 AM PDTC.E. CREDITS
OCT 09, 2019 10:30 AM PDTA subset of women with ovarian cancer will present with an apparently isolated adnexal mass. Many of these women will have early stage ovarian cancer with a relatively good prognosis. Unfortu...Speaker: Mitchel Hoffman, MDPresented at: Cancer Research & Oncology 2019OCT 03, 2019 3:00 PM PDTC.E. CREDITS
OCT 03, 2019 3:00 PM PDTNovel precision genetic technologies such as CRISPR/Cas9 genome editing technology offer novel avenues to a better understanding the mechanisms of diseases. Using CRISPR/Cas9 we are able to p...Speaker: Gaetan Burgio, Msc, MBBS, MD, PhDPresented at: CRISPR 2019JAN 31, 2019 7:30 AM PSTC.E. CREDITS
JAN 31, 2019 7:30 AM PSTProdrugs are harmless in their native state, as they are not targeted by human enzymes. But they can be converted into highly toxic compounds (the “drug”) by viral or bacterial en...Speaker: A.C. Matin, PhDPresented at: BioProcessing 2019OCT 11, 2018 1:30 PM PDT
OCT 11, 2018 1:30 PM PDTRecent work has identified epigenomic features of distal regulatory elements to be dynamic and defining indicators of cellular specification and transformation. Of particular relevance is our...Speaker: Martin Hirst, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 1:30 PM PDT
OCT 11, 2018 1:30 PM PDTAs the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...Speaker: Benjamin Anderson, MDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 12:00 PM PDT
OCT 11, 2018 12:00 PM PDTAlthough targeted therapies often elicit profound initial patient responses, these effects are transient due to residual disease leading to acquired resistance. How tumors transition between...Speaker: Khyati Shah, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 12:00 PM PDT
OCT 11, 2018 12:00 PM PDTLung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...Speaker: Nicholas McGranahan, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 10:30 AM PDT
OCT 11, 2018 10:30 AM PDTAntibodies are extremely valuable and ubiquitous tools in life science research, but in spite of their widespread use in immunoassays over the past several decades, there is still a lack of u...Speaker: Chandra Mohan, PhDPresented at: Cancer Research & Oncology 2018Sponsored By: MilliporeSigmaOCT 11, 2018 10:30 AM PDT
OCT 11, 2018 10:30 AM PDTTwo projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...Speaker: Kevin Williams, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 9:00 AM PDT
OCT 11, 2018 9:00 AM PDTThe oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...Speaker: Jason De Melo, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 9:00 AM PDT
OCT 11, 2018 9:00 AM PDTIn the last two decades, large amount of next-generation sequencing (NGS) and -omics data has been generated in the field of immuno-oncology. Generating hypotheses by analyzing hundreds if no...Speaker: Devendra Mistry, PhDPresented at: Cancer Research & Oncology 2018Sponsored By: QIAGENOCT 11, 2018 7:30 AM PDT
OCT 11, 2018 7:30 AM PDTIn the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...Speaker: Krastan Blagoev, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 6:00 AM PDT
OCT 11, 2018 6:00 AM PDTPacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...Speaker: Jonas Korlach, PhDPresented at: Cancer Research & Oncology 2018OCT 10, 2018 12:00 PM PDT
OCT 10, 2018 12:00 PM PDTRNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...Speaker: Jonathan Shaffer, MBA, PhDPresented at: Cancer Research & Oncology 2018Sponsored By: QIAGENOCT 10, 2018 12:00 PM PDT
OCT 10, 2018 12:00 PM PDTTo date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...Speaker: Jerome Galon, PhDPresented at: Cancer Research & Oncology 2018
OCT 08, 2020
7:30 AM PDT
C.E. CREDITS
OCT 08, 2020
7:30 AM PDT
Individuals of under-represented minority ancestry are at disproportional risk for higher incidence and mortality rates for particular cancers. The unequal burden of cancer in certain racial...
Speaker:
Steven R. Patierno, PhD
Presented at: Cancer Research & Oncology 2020
JUN 17, 2020
12:00 PM PDT
C.E. CREDITS
JUN 17, 2020
12:00 PM PDT
Join us and hear from two Luminex® experts on our flexible solutions for molecular diagnostics. Dr. Sherry Dunbar and Dr. Aaron Benfield will describe our NxTAG® bead-based nucleic a...
Speaker:
Aaron P. Benfield, PhD
,
Sherry A. Dunbar, PhD, MBA
Presented at: Coronavirus Virtual Event SeriesSponsored By: LUMINEX
OCT 10, 2019
1:30 PM PDT
C.E. CREDITS
OCT 10, 2019
1:30 PM PDT
Metastatic castration resistant prostate cancer (mCRPC) refractory to secondary hormonal treatments such as enzalutamide or abiraterone acetate are the most lethal of prostate cancers. In thi...
Speaker:
Tian Zhang, MD, MHS
Presented at: Cancer Research & Oncology 2019
OCT 10, 2019
12:00 PM PDT
C.E. CREDITS
OCT 10, 2019
12:00 PM PDT
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
Speaker:
Ravindra Kolhe, MD, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: QIAGEN
OCT 10, 2019
10:30 AM PDT
C.E. CREDITS
OCT 10, 2019
10:30 AM PDT
Osteosarcoma (OS) is the most common bone tumor in pediatric and adolescent/young adult patients. Over the past three decades, significant improvements in the survival rates or therapeutic ap...
Speaker:
Troy McEachron, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: NanoString Technologies
OCT 10, 2019
10:30 AM PDT
C.E. CREDITS
OCT 10, 2019
10:30 AM PDT
Accumulation of structural variations (SVs) across the genome is a known trigger factor for oncogenesis. Structural mutations have been clearly implicated in a number of cancers, most notably...
Speaker:
Sven Bocklandt, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: Bionano Genomics
OCT 10, 2019
9:00 AM PDT
C.E. CREDITS
OCT 10, 2019
9:00 AM PDT
Copy-number alterations and chromosomal translocations are widespread in cancer and frequently causing oncogenic mutations that drive tumorigenesis and therapy resistance. Despite their preva...
Speaker:
Cheng-Zhong Zhang, PhD
Presented at: Cancer Research & Oncology 2019
OCT 10, 2019
9:00 AM PDT
C.E. CREDITS
OCT 10, 2019
9:00 AM PDT
Blockade of CTLA-4 and PD-1, members of the B7/CD28 family, have proven to be the most successful cancer immunotherapies to date. While the current therapeutic focus remains on B7/CD28 family...
Speaker:
Anthony Persen, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: Bio-Techne
OCT 09, 2019
12:00 PM PDT
C.E. CREDITS
OCT 09, 2019
12:00 PM PDT
The introduction of robot-assisted surgical technology into urological practice, has introduced new horizons for reducing the morbidity and enhancing the efficacy of surgery. Open radical cys...
Speaker:
Khurshid Guru, MD
Presented at: Cancer Research & Oncology 2019
OCT 09, 2019
10:30 AM PDT
C.E. CREDITS
OCT 09, 2019
10:30 AM PDT
A subset of women with ovarian cancer will present with an apparently isolated adnexal mass. Many of these women will have early stage ovarian cancer with a relatively good prognosis. Unfortu...
Speaker:
Mitchel Hoffman, MD
Presented at: Cancer Research & Oncology 2019
OCT 03, 2019
3:00 PM PDT
C.E. CREDITS
OCT 03, 2019
3:00 PM PDT
Novel precision genetic technologies such as CRISPR/Cas9 genome editing technology offer novel avenues to a better understanding the mechanisms of diseases. Using CRISPR/Cas9 we are able to p...
Speaker:
Gaetan Burgio, Msc, MBBS, MD, PhD
Presented at: CRISPR 2019
JAN 31, 2019
7:30 AM PST
C.E. CREDITS
JAN 31, 2019
7:30 AM PST
Prodrugs are harmless in their native state, as they are not targeted by human enzymes. But they can be converted into highly toxic compounds (the “drug”) by viral or bacterial en...
Speaker:
A.C. Matin, PhD
Presented at: BioProcessing 2019
OCT 11, 2018
1:30 PM PDT
OCT 11, 2018
1:30 PM PDT
Recent work has identified epigenomic features of distal regulatory elements to be dynamic and defining indicators of cellular specification and transformation. Of particular relevance is our...
Speaker:
Martin Hirst, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
1:30 PM PDT
OCT 11, 2018
1:30 PM PDT
As the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...
Speaker:
Benjamin Anderson, MD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
12:00 PM PDT
OCT 11, 2018
12:00 PM PDT
Although targeted therapies often elicit profound initial patient responses, these effects are transient due to residual disease leading to acquired resistance. How tumors transition between...
Speaker:
Khyati Shah, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
12:00 PM PDT
OCT 11, 2018
12:00 PM PDT
Lung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...
Speaker:
Nicholas McGranahan, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
10:30 AM PDT
OCT 11, 2018
10:30 AM PDT
Antibodies are extremely valuable and ubiquitous tools in life science research, but in spite of their widespread use in immunoassays over the past several decades, there is still a lack of u...
Speaker:
Chandra Mohan, PhD
Presented at: Cancer Research & Oncology 2018Sponsored By: MilliporeSigma
OCT 11, 2018
10:30 AM PDT
OCT 11, 2018
10:30 AM PDT
Two projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...
Speaker:
Kevin Williams, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
9:00 AM PDT
OCT 11, 2018
9:00 AM PDT
The oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...
Speaker:
Jason De Melo, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
9:00 AM PDT
OCT 11, 2018
9:00 AM PDT
In the last two decades, large amount of next-generation sequencing (NGS) and -omics data has been generated in the field of immuno-oncology. Generating hypotheses by analyzing hundreds if no...
Speaker:
Devendra Mistry, PhD
Presented at: Cancer Research & Oncology 2018Sponsored By: QIAGEN
OCT 11, 2018
7:30 AM PDT
OCT 11, 2018
7:30 AM PDT
In the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...
Speaker:
Krastan Blagoev, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
6:00 AM PDT
OCT 11, 2018
6:00 AM PDT
PacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...
Speaker:
Jonas Korlach, PhD
Presented at: Cancer Research & Oncology 2018
OCT 10, 2018
12:00 PM PDT
OCT 10, 2018
12:00 PM PDT
RNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...
Speaker:
Jonathan Shaffer, MBA, PhD
Presented at: Cancer Research & Oncology 2018Sponsored By: QIAGEN
OCT 10, 2018
12:00 PM PDT
OCT 10, 2018
12:00 PM PDT
To date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...
Speaker:
Jerome Galon, PhD
Presented at: Cancer Research & Oncology 2018
- Adipose Tissue
- Hazard
- Mammals
- Bones
- Bacteria
- CAR T-Cells
- Cell Morphology
- Bone Marrow
- Bone Diseases
- Bone Development
- Bone Biology
- Glioma
- Publishing
- Monoclonal Gammopathy
- Dementia
- Glioblastoma
- Mitochondria
- Nano Biomedicine
- Reproductiive Health
- Toxin
- Digestion
- Tumor Markers
- Multiple Myeloma
- Cell
- Hematologic Cancers
- Cancer
- Research and Development
- Tumor
- Lymphoma
- Proliferation
- Fat
- Horse
- Gene
- Hematology
- Research
- Lung Cancer
- Cell Differentiation
- DNA Damage
- Disease
- T-Cells
- Prostate Cancer
- Molecular Techniques
- Wellness
- Immunotherapeutics
- Infusion
- Lab Safety
- Molecular Genetics
- Virus
- Colorectal
- Clinical Medicine
- Visualization
- Health
- Respiratory
- Anemia
- Cannabinoid Research
- CT Scan
- Drug Formulation
- GMO
- Human Papillomavirus (HPV) DNA Tests
- Drift
- Human Papillomavirus HPV
- HPV
- Cannabidiol
- Cannabis Medicine
- Telomerase
- Food Supplement
- Immunity
- Single Cell
- Skin
- One Health
- Brain
- Sequencing
- Brain Health
- Immune System
- Clinical Evaluation
- Cytotoxicity
- Inflammation
- Environmental Science
- Melanoma
- Mutation
- Environment
- Clinical Genetics
- Genetic Engineering
- Histopathology
- Animal Cloning
- Lymphocytes
- Cellular Differentiation
- Engineering
- Therapy
- Cancer Research
- Pancreatic Cancer
- Carcinoma
- Ovarian Cancer
- Medicine
- Protein
- Cell Signaling
- Yeast
- Mouse
- Pluripotency
- Antibiotics
- Gene Silencing
- Radiation
- Radiation Oncology
- DNA
- Analytics
- Translational Research
- Aging Population
- Environmental Health
- Healthcare IT
- Functional Medicine
- Life Sciences
- Cell Proliferation
- Healthcare
- Fusion
- Cellular Mechanism
- Neurodegeneration
- Brain Diseases
- Personality
- Breast Cancer
- Blood Collection
- Information Technology
- Genetics
- Cancer Cell
- Animal Research
- Immunotherapy
- Animals
- Gene Regulation
- T Cell
- Cell Biology
- Oncology
- Laboratory
- Case Study
- Human Genetics
- T-cell Receptor
- Leukemia
- Lungs
- Brain Cancer
- Personalized Medicine
- Tumor Targeting
- Liver
- Space
- Liver Cancer
- Infection
- Myeloma
- Single Cell Diagnostics
- Molecular Neurobiology
- Cell Expansion
- Allergy
- ALS
- Nanoparticles
- Neurobiology
- Neurodegenerative Disease
- NASA
- Infection Control
- Brain Damage
- Protein Characterization
- Molecular Biology
- Population Health
- University
- Biomedical Research
- Science
- Cancer Stem Cells
- Data Science
- Stem Cell Markers
- Brain Initiative
- Sequence Analysis
- Diagnosis
- Drug Development
- Disease Modeling
- Molecular Pathology
- Health Technology
- Stem Cells
- Cancer Biology
- Cancer Metabolism
- Stem Cell Research
- In Vivo
- Cancer Therapeutics
- Clinical Research
- Therapeutics
- Cell Line Development
- Behavior
- Pre-clinical Research
- Biology
- Tumor Microenvironment
- Treatment of Cancer
- Cancer Treatment
- Laboratory Medicine
- Information System
- Protein Engineering
- Education
- Comparative Genomics
- Cancer Diagnostics
- Control System
- Solution
- Clinical Oncology
- Experiment
- Preventive Medicine
- Cell Therapy
- Enhancer
- Brain Tumor
- Population Genetics
- Technology
- Genomics
- Neuron
- Complex Disease
- Gene Expression
- Pathology
- Single Cell Organism
- Pharmacy Sciences
- Pharma Research
- Molecular Diagnostics
- Clinical Biochemistry
- Coding
- Pancreatitis
- Communication
- Case-Control Study
- Method Validation
- Computational Biology
- Behavioral Research
- Laboratory Methods
- Data Analysis
- Chronic Disease
- DNA Profiling
- Protein Structure
- Diagnostics
- Gene Therapy
- Neurology
- Neuroscience
- Virology
- Clinical Trials
- Viral Vectors
- Cell Death
- Bioengineering
- Clinical Virology
- Molecular Neuroscience
- Molecular Pathogenesis
- Tolerance
- Viral Cell Culture
- History
- Environmental Protection
- Pathophysiology
- Reproduction
- Molecular Modelling
- Gene Sequencing
- Protein Expression
- Cancer Prevention
- Blood Cancer
- Biomarkers
- Clinical Diagnostics
- Phenotype
- Antibodies
- Cell Imaging
- Life Science
- Clinical Laboratory
- Medical Genetics
- Genetic Testing
- Biochemistry
- Blood
- Human Biology
- Biomedical Sciences
- Animal Models
- Infectious Disease
- Systems Biology
- Primary Cells
- Pharmaceutical Testing
- DNA Sequencing
- Targeted Therapy
- Single-Molecule
- Complex Systems
- Biotechnology
- Translational Medicine
- Molecular Dynamics
- Cancer Biomarker
- General Medicine
- Microbiology
- Genome Editing
- Metastasis
- Cell Cycle
- Single Cell Sequencing
- Cancer Genomics
- Laboratory Testing
- Apoptosis
- Enzyme
- In-Vivo Research
- Animal Production
- Medical Technology
- Functional Genomics
- CRISPR-Cas9
- Precision Medicine
- Imaging
- Stem Cell Therapy
- NGS
- Continuing Education
- Computational Model
- Mathematics